Overview
Translational Advances in Cancer Prevention Agent Development (TACPAD) – 4th Biennial Virtual Meeting
Sponsored by the Division of Cancer Prevention, NCI, NIH.
Date: September 28–30, 2026
Location: Virtual Meeting
Meeting Objectives
The main goals of the meeting are to:
- Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention/interception researchers from basic and clinical research,
- Highlight new and emerging trends in the clinical and preclinical space impacting the development of immunoprevention and chemoprevention agents, and
- Promote prevention agent development and rapid translation to clinical trials and engage cancer researchers with novel prevention concepts.
Agenda Topics
Plenary Session
- Emerging Targets, Vaccines and Immunomodulatory Agents for Cancer Prevention
- Molecularly Targeted Novel Agents for Cancer Prevention and Interception
- Clinically relevant alternative models for cancer prevention
- Cancer Prevention-Interception Clinical Trials
- Panel Discussion – Biomarkers as intermediate end points for cancer prevention clinical trials
- Early Investigator Flash Talks
- Meet with the NCI Program Directors
Planning Committee
- Goli Samimi
- Howard Parnes
- Kajal Biswas
- Gabriela Riscuta
- Indu Kohaar
- Anda Vlad
- Brian Cholewa
- Altaf Mohammed
Program Support
Marsha Greco
Meeting Organizers
Altaf Mohammed, Ph.D.
Deputy Chief, CADRG1/NSRG
Division of Cancer Prevention, NCI
Email: altaf.mohammed@nih.gov
Phone: 240-276-6082
Brian Cholewa, Ph.D.
Deputy Chief, CADRG2
Division of Cancer Prevention, NCI
Email: brian.cholewa@nih.gov
Phone: 240-276-7545
General Information
For meeting questions, please contact:
Altaf Mohammed, Ph.D.
Deputy Chief, CADRG1/NSRG
Division of Cancer Prevention, NCI
Email: altaf.mohammed@nih.gov
Phone: 240-276-6082
Marsha Greco
Program Specialist
CADRG, NCI
National Institutes of Health
Email: Marsha.greco@nih.gov